Hainan Huluwa Pharmaceutical Group Co Ltd Sustainability Reports
The company researches, develops, manufactures, and markets pediatric and adult medications in China. Its focus includes traditional Chinese medicine and chemical drugs for respiratory, digestive, and anti-infective treatment.
Sector: Manufacturing
Country: China
Exchange: Shanghai Stock Exchange
FIGI: BBG00PDLF8T8
4 reports from 2022 to 2025
